Refresh

Aarey Drugs & Pharmaceuticals Ltd. - Research Center

524412 AAREYDRUGS Group (T) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

418.96 492.68 348.42 300.09 354.74
Expenses

Material consumed

403.84 472.06 337.79 290.18 340.97

Manufacturing expenses

- - - - -

Personnel expenses

0.81 0.98 0.40 0.40 0.47

Selling expenses

- - - 0.03 -

Adminstrative expenses

6.58 8.37 5.59 6.24 5.41

Expenses capitalised

- - - - -

Cost of sales

411.23 481.41 343.78 296.86 346.86

Operating profit

7.72 11.27 4.64 3.23 7.89

Other recurring income

2.73 2.75 7.01 6.69 4.34

Adjusted PBDIT

10.45 14.02 11.65 9.92 12.22

Financial expenses

2.87 2.00 2.43 1.79 2.23

Depreciation

1.57 1.99 0.92 0.89 1.01

Other write offs

- - - - -

Adjusted PBT

6.01 10.03 8.30 7.24 8.99

Tax charges

2.24 3.48 1.79 1.45 2.44

Adjusted PAT

3.77 6.54 6.51 5.79 6.54

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

3.77 6.54 6.51 5.79 6.54

Earnigs before appropriation

48.42 44.65 38.11 31.59 26.03

Equity dividend

- - - - 0.23

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

48.42 44.65 38.11 31.59 25.80
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com